A record of what ETMarkets Analysis said publicly, with the source. Not advice.
Pending — not yet graded
“Divi's Laboratories has broken out from a downward-sloping trendline, suggesting potential for upward movement. Medium-term traders are advised to buy the stock with a target above ₹7,000 levels within the next 3-4 months, supported by strong price action, trading above key moving averages, and higher volume during the breakout.”
ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%
Divi's LaboratoriesBullishCalled 15 Oct 2025
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.